Skip to main content
. 2021 Jan 6;16:3. doi: 10.1186/s11671-020-03452-4

Table 2.

Relation between clinicopathological features and expression of miR-301 and PTEN in ESCC patients

Clinicopathological feature N Expression of miR-301 P value PTEN mRNA expression P value
High expression
(n = 55)
Low expression
(n = 55)
High expression
(n = 55)
Low expression
(n = 55)
Age (years)
 > 60 84 44 40 0.501 41 43 0.823
 ≤ 60 26 11 15 14 12
Gender
 Male 78 37 41 0.529 36 42 0.294
 Female 32 18 14 19 13
TNM stage
 I + II 60 20 40 < 0.001 38 22 0.004
 III 50 35 15 17 33
LNM
 No 71 27 44 0.001 38 23 0.007
 Yes 39 28 11 17 32
Tumor size (cm)
 ≥ 5 65 35 30 0.438 29 36 0.244
 < 5 45 20 25 26 19
Tumor differentiation
 Moderate and high differentiation 78 35 43 0.141 44 34 0.058
 Poor differentiation 32 20 12 11 21
Tumor location
 Upper 13 8 5 0.556 5 8 0.556
 Mid-lower 97 47 50 50 47

TNM, tumor–node–metastasis; LNM, lymph node metastasis